从虚、瘀、浊论治肿瘤相关性失眠经验介绍

打开文本图片集

[中图分类号］R249 [文献标志码］A [文章编号]0256-7415（2025）18-0149-05

DOl：10.13457/j.cnki.jncm.2025.18.028

Introduction of DING Jiyuan's Experience in Managing Cancer-Related Insomnia from Deficiency-Stasis-Turbidity Syndrome Differentiation

ZHANG Luxin1，YANG Guoliang²，ZHANG Yaoyao²，XU Ling² Instructor：DING Jiyuan² 1.TheSecondScholofClinicalMedicineofZhejiangChineseMedicalUniversity，HangzhouZhejang310o1，China；2.Departentf Oncology and Hematology，Hangzhou Red Cross Hospital，Hangzhou Zhejiang 31oooo，China

Abstract：This article introduces DING Jiyuan's clinical experience in treating cancer-related insomnia（CRI） fromdeficiency-stasis-turbiditysyndromediferentiation．DING Jiyuancontends that CRIoriginates from deficiencyas theroot cause，manifestsas stasisas thebranch manifestation，and evolves through turbidityas the pathological transformation，withthese threefactorsdynamicall interacting todrive thedisease．Clinically，heisadeptatstarting from the dynamic pathogenesis ofthe binding ofdeficiency，stasis and turbidity．He often uses three herbs，namely PseudostelariaeRadix，Astragali Radix，andRehmanniaeRadix Praeparata to treat therootcauseas qi-blood deficiency.He uses Persicae Semen and Carthami Flos to treat the branch as blood stasis obstructionand stagnation， and heuses Pineliae Rhizoma，Citri Reticulatae Pericarpium，and Atractylodis Macrocephalae Rhizoma to disperse phlegm-turbidityaccumulation．Guided bythefour-factor considerationprinciple，integrating the patient's treatment course，pathogen predominance，cancer type，and disease stage，DING's disease-syndrome integrated approach achieves significant clinical effect.

KeyWords：Cancer-related insomnia；Deficiency-stasis-turbidity；Four-factor consideration；DING Jiyuan

丁纪元主任中医师为杭州市名中医、杭州市红十字会肿瘤血液科主任，从事临床、教学工作30余载。（剩余6955字）